Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

115.76
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
96.18
Today|||52-Week Range
149.34
-5.39%
Year-to-Date
Alexion (ALXN) in Focus: Stock Moves 7.2% Higher
Dec 11 / Zacks.com - Paid Partner Content
4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018
Dec 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close115.76
Today’s open114.07
Day’s range112.50 - 116.55
Volume3,412,397
Average volume (3 months)1,932,365
Market cap$25.9B
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+22.37%
Earnings growth (next 5 years)+19.05%
Revenue growth (last year)+21.11%
P/E ratio51.7
Price/Sales9.22
Price/Book2.98

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc0.000.00%
BAXBaxter International...0.000.00%
INCYIncyte Corp0.000.00%
VRTXVertex Pharmaceutica...0.000.00%
Data as of 4:15pm ET, 12/15/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$1.27
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts